Cortex Discovery hat dies direkt geteilt
Exciting AI-Driven Innovation for Drug Discovery at NLSD: I’m thrilled to introduce Cortex Discovery's cutting-edge deep learning technology, which predicts molecular properties with accuracy that rivals experimental methods. Validated across multiple therapeutic areas, this innovation has led to new preclinical leads at negligible cost. We offer a wide range of services including: 🔹 Virtual High Throughput Screening 🔹 ADMET & off-target predictions 🔹 Virtual hit analog identification 🔹 De novo compound creation Our extensive libraries—ranging from FDA-approved to novel compounds—enable fast compound ordering. We specialize in seamless CRO collaborations, and can handle hit discovery and lead optimization in a single process. Next-gen Molecular Docking: Our new prototype, combining deep neural networks and molecular simulations (ultimately reaching the quantum level), allows for the fast exploration of new targets even without activity data, delivering unprecedented prediction accuracy—1000x faster than available alternatives. We are also partnering with leading labs to advance compounds for age-related disorders and life extension. Notably, we developed the first AI-discovered drug that extended lifespan in C. elegans by 33%. I would be happy to meet and discuss collaboration opportunities at NLSD! #AI #DrugDiscovery #virtualHTS #VirtualADMET #LifeExtension #Oncology #DeepLearning #Biotech #NLSD2024 #CortexDiscovery